Macrolides and methods of their preparation and use

US10913764B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10913764-B2
Application numberUS-201815946658-A
CountryUS
Kind codeB2
Filing dateApr 5, 2018
Priority dateApr 4, 2013
Publication dateFeb 9, 2021
Grant dateFeb 9, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are methods of preparing macrolides by the coupling of an eastern and western half, followed by macrocyclization, to provide macrolides, including both known and novel macrolides. Intermediates in the synthesis of macrolides including the eastern and western halves are also provided. Pharmaceutical compositions and methods of treating infectious diseases and inflammatory conditions using the inventive macrolides are also provided. A general diastereoselective aldol methodology used in the synthesis of the western half is further provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of formula: or a salt thereof; wherein: Z is a group of formula: wherein: L 1 and L 2 are each a bond; z1 and z2 are each independently 0 or 1; each instance of R 1a , R 1b , R 2a , and R 2b is independently hydrogen, halogen, carbonyl, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, or optionally substituted heteroaryl, or wherein R 1 a and R 1b or R 2a and R 2b can be taken together to form R Z2 is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, —C(═O)R Z8 , —C(═O)OR Z8 , —C(═O)N(R Z8 ) 2 , or a nitrogen protecting group; R Z3 is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, or optionally substituted heteroaryl; L 3 is a group of formula: represents a single or double bond; R 3 is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, —C(═O)R Z8 , —C(═O)OR Z8 , —C(═O)N(R Z8 ) 2 , an oxygen protecting group, or a group of formula: R 4 is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, or optionally substituted heteroaryl; each instance of R 18 and R 19 independently hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, or optionally substituted heteroaryl; each instance of R 20 and R 21 is independently hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, hydroxyl, substituted hydroxyl, thiol, substituted thiol, amino, substituted amino, halogen, or carbonyl, or R 20 and R 21 are joined to form an optionally substituted cyclopropyl or an oxiranyl ring; each instance of R 5a and R 5b is independently hydrogen or optionally substituted alkyl; R 6 is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, optionally substituted heteroaralkyl, hydroxyl, substituted hydroxyl, thiol, substituted thiol, amino, substituted amino, carbonyl, silyl, or halogen; R 7 and R 8 are each independently optionally substituted alkyl; R 9 is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, C(═O)R Z8 , C(═O)OR Z8 , —C(═O)N(R Z8 ) 2 , an oxygen protecting group, or a carbohydrate; R 10 is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, hydroxyl, substituted hydroxyl, thiol, substituted thiol, amino, substituted amino, carbonyl, silyl, or halogen; G 3 is —O—; G 1 is —NR 13 R 14 ; R 11 and R 13 are joined as a group of formula —C(═O)- to provide a cyclic carbamate; R 14 is hydrogen; each instance of L C1 and L C2 is independently a bond, or a linking group selected from the group consisting of optionally substituted alkylene, optionally substituted alkenylene, optionally substituted alkynylene; optionally substituted heteroalkylene, optionally substituted heteroalkenylene, optionally substituted heteroalkynylene, and combinations thereof; each instance of A 1 is independently a leaving group (LG), A is R W2 is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, or optionally substituted heteroaryl, or two R W2 groups are joined to form an optionally substituted cyclic moiety; R 23 is optionally substituted alkyl optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl optionally substituted heterocyclyl, optionally substituted aryl, or optionally substituted heteroaryl; and each instance of R Z8 is independently hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, or optionally substituted heteroaryl, or two R Z8 groups are joined to form an optionally substituted heterocyclyl or optionally substituted heteroaryl ring. 2. The compound of claim 1 , wherein the compound is of formula: or a salt thereof. 3. The compound of claim 1 , wherein the compound is of formula: or a salt thereof. 4. The compound of claim 1 or 2 , or a salt thereof, wherein L 1 and L 2 are each a bond; z1 and z2 are each 1; each instance of R 1a , R 1b , R 2a , and R 2b is independently hydrogen, optionally substituted alkyl, optionally substituted alkenyl, or optionally substituted carbocyclyl; R Z2 is hydrogen, optionally substituted alkyl, or —C(═O)R Z8 ; and R Z3 is hydrogen or optionally substituted alkyl. 5. The compound of claim 1 , or a salt thereof, wherein L 3 is a group of formula: 6. The compound of claim 5 , or a salt thereof, wherein R 3 is optionally substituted alkyl. 7. The compound of claim 1 , or a salt thereof, wherein R 3 is a group of formula: 8. The compound of claim 7 , or a salt thereof, wherein R 23 is of formula:

Assignees

Inventors

Classifications

  • C07H17/00Primary

    Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals · CPC title

  • Bridged systems · CPC title

  • Antibacterial agents · CPC title

  • containing six-membered rings with nitrogen as a ring hetero atom · CPC title

  • containing five-membered rings with nitrogen as a ring hetero atom · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10913764B2 cover?
Provided herein are methods of preparing macrolides by the coupling of an eastern and western half, followed by macrocyclization, to provide macrolides, including both known and novel macrolides. Intermediates in the synthesis of macrolides including the eastern and western halves are also provided. Pharmaceutical compositions and methods of treating infectious diseases and inflammatory conditi…
Who is the assignee on this patent?
Harvard College
What technology area does this patent fall under?
Primary CPC classification C07H17/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).